IRDye® 700DX Infrared Dyes by LI-COR Biosciences
Manufacturer LI-COR Biosciences | Available Worldwide
IRDye 700DX has shown potential as a molecular-targeted cancer therapy, or photoimmunotherapy (PIT), also called photodynamic therapy. The phthalocyanine dye IRDye 700DX has robust properties that make it suitable for optical imaging when conjugated to antibodies, receptor-binding ligands, small molecules, and more.
It is considerably less sensitive to photobleaching than many other organic fluorochromes, and has excellent water solubility and salt tolerance. IRDye 700DX is available as an N... Read more
IRDye® 700DX Infrared Dyes
IRDye 700DX has shown potential as a molecular-targeted cancer therapy, or photoimmunotherapy (PIT), also called photodynamic therapy. The phthalocyanine dye IRDye 700DX has robust properties that make it suitable for optical imaging when conjugated to antibodies, receptor-binding ligands, small molecules, and more.
It is considerably less sensitive to photobleaching than many other organic fluorochromes, and has excellent water solubility and salt tolerance. IRDye 700DX is available as an NHS ester and in labeling kits. Other forms are available through LI-COR Custom Services.
Features:
- NHS ester reactive group for labeling primary and secondary amino groups
- Potential as a molecular-targeted cancer therapy, or photoimmunotherapy (PIT)1
- Excellent photostability, water solubility, and salt tolerance2
- Alternative to Quantum Dots
Product Overview
IRDye® 700DX Infrared Dyes
Manufacturer LI-COR Biosciences | Available Worldwide
Be the first to review this product
